Cost-Utility Analysis of Bosutinib for Previously Treated Chronic Myeloid Leukemia (Cml) In Portugal
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.1695
https://www.valueinhealthjournal.com/article/S1098-3015(14)03625-0/fulltext
Title :
Cost-Utility Analysis of Bosutinib for Previously Treated Chronic Myeloid Leukemia (Cml) In Portugal
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03625-0&doi=10.1016/j.jval.2014.08.1695
First page :
A533
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1174